Stereological evaluation of human spermatogenesis after suppression by testosterone treatment: Heterogeneous pattern of spermatogenic impairment

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 4, 1998, Pages 1284-1291

  Zhengwei, Yang ^a   Wreford, Nigel G ^a,b   Royce, Peter ^b   De Kretser, David M ^a   McLachlan, Robert I ^a,c  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE ENANTATE;

ADULT; ARTICLE; AZOOSPERMIA; DRUG EFFECT; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; IMMUNOCYTOCHEMISTRY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SERTOLI CELL; SPERMATOGENESIS; SPERMATOGONIUM; STEREOLOGY; TESTIS BIOPSY; VASECTOMY;

ADULT; CASE-CONTROL STUDIES; CONTRACEPTIVE AGENTS, MALE; DEPRESSION, CHEMICAL; FOLLICLE STIMULATING HORMONE; HUMANS; INHIBINS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; SPERM COUNT; SPERMATOGENESIS; TESTOSTERONE;

ILEX COOKII;

EID: 0031764875     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.4.1284     Document Type: Article

References (46)

1. Heckel NJ. 1940 The influence of testosterone-propionate upon benign prostatic hypertrophy and spermatogenesis: a clinical and pathological study in the human. J Urol. 43:286-308.
2. McCullagh EP, Rossmiller HR. 1941 Methyl testosterone. I. Androgenic effects and the production of gynecomastia and oligospermia. J Clin Endocrinol. 1:496-506.
3. Heller CG, Nelson WO, Hill IB, et al. 1950 Improvement in spermatogenesis following depression of the human testis with testosterone. Fertil Steril. 1:415-422.
4. Heller CG, Laidlaw WM, Harvey HT, Nelson WO. 1958 Effects of progestational compounds on the reproductive processes of the human male. Ann NY Acad Sci. 71:649-665.
5. Steinberger E, and Smith KD. 1977 Effect of chronic administration of testosterone enanthate on sperm production and plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels: a preliminary evaluation of a possible male contraceptive. Fertil Steril. 28:1320-1328.
6. Schearer SB, Alvarez-Sanchez F, Anselmo J, et al. 1978 Hormonal contraception for men. Int J Androl. 2(Suppl):680-712.
7. Rowley MJ, Heller CG. 1978 Summary of studies utilising androgens in the normal human male. In: Patanelli DJ, ed. Hormonal control of male fertility. DHEW, Publication (NIH) 78-1097. Washington DC: US Government Printing Office; 145-166.
8. Swerdloff RS, Palacios A, McClure RD, Campfield LA, Brosman SA. 1978 Male contraception: clinical assessment of chronic administration of testosterone enanthate. Int J Androl. 2(Suppl):731-747.
9. Swerdloff RS, Wang C, Bhasin S. 1989 Male contraception: 1988 and beyond. In: Burger H, de Kretser DM, eds. The testis. New York: Raven Press; 547-568.
10. WHO Task Force on Methods for the Regulation of Male Fertility. 1990 Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet. 336:955-959.
11. WHO Task Force on Methods for the Regulation of Male Fertility. 1996 Contraceptive efficacy of testosterone-induced azoospermia and oligospermia in normal men. Fertil Steril. 65:821-829.
12. Handelsman DJ, Farley TM, Peregoudov A, Waites GMH, WHO Task Force on Methods for the Regulation of Male Fertility. 1995 Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. Fertil Steril. 63:125-133.
13. Wallace EM, Gow SM, Wu FCW. 1993 Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I. Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. J Clin Endocrinol Metab. 77:290-293.
14. Anderson RA, Wu FCW. 1996 Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate. J Clin Endocrinol Metab. 81:896-901.
15. Anderson RA, Wallace AM, Wu FCW. 1996 Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5α-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. J Clin Endocrinol Metab. 81:902-908.
16. McLachlan, Wreford NG, O'Donnell L, de Kretser DM, Robertson DM. 1996 The endocrine regulation of spermatogenesis: independent roles for testosterone and FSH. J Endocrinol. 148:1-9.
17. Frick J. 1973 Control of spermatogenesis in men by combined administration of progestin and androgen. Contraception. 8:191-206.
18. Frick J. 1975 Effects of steroids on spermatogenesis. In: Sciarra JJ, Markland C, Speidel JJ, eds. Control of male fertility. New York: Harper and Row; 230-239.
19. Frick J, Bartsch G, Weiske WH. 1977 The effect of monthly depot medroxy-progesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels. Contraception. 15:649-668.
20. WHO. 1992 WHO laboratory manual for the examination of human semen, and sperm-cervical mucus interaction. Geneva: WHO; 3-27.
21. Zhengwei Y, Wreford NG, Bremner WJ, Matsumoto AM, Anawalt BA, McLachlan RI. 1998 Immature spermatids are not prevalent in human semen during androgen-based contraceptive regimens. Fertil Steril. 69:89-95.
22. Zhengwei Y, Wreford NG, Bremner WJ, McLachlan RI. 1997 Stereological analysis of germ cell numbers in the adult macaque. J Androl. 18:681-687.
23. Clermont Y. 1963 The cycle of the seminiferous epithelium in man. Am J Anat. 112:35-51.
24. Clermont Y. 1966a Renewal of spermatogonia in man. Am J Anat. 118:509-524.
25. Clermont Y. 1966b Spermatogenesis in man: a study of the spermatogonial population. Fertil Steril. 17:705-721.
26. Clermont Y. 1970 Dynamics of human spermatogenesis. In: Rosemberg E, Paulsen CA, eds. The human testis, New York: Plenum Press; 47-61.
27. Sharpe RM. 1994 Regulation of spermatogenesis. In: The physiology of reproduction, 2nd ed. Knobil E, Neil JD, eds. New York: Raven Press; 1363-1434.
28. Sterio DC. 1984 The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc. 134:127-136.
29. Gundersen HJG, Bagger P, Bendsten TF, et al. 1988 The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 96:857-881.
30. Baddeley AJ, Gundersen HJG, Cruz-Orive LM. 1986 Estimation of surface area from vertical sections. J Microsc. 142:259-276.
31. Jensen EB, Gundersen HJG. 1993 The rotator. J Microsc. 170:35-44.
32. Wreford NG. 1995 Theory, and practice of stereological techniques applied to the estimation of cell number and nuclear volume in the testis. Microsc Res Technique. 32:423-436.
33. Anawalt BD, Bebb RA, Matsumoto AM, et al. 1996 Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab. 81:3341-3345.
34. MacLeod J. 1970 The significance of deviations in human sperm morphology. In: Rosemberg E, Paulsen CA, eds. The human testis. New York: Plenum Press; 481-494.
35. Ulstein M, Netto N, Leonard J, Paulsen CA. 1975 Changes in sperm morphology in normal men treated with danazol and testosterone. Contraception. 12:437-444.
36. Zhengwei Y, Wreford NG, Schlatt S, Weinbauer GF, Nieschlag E, McLachlan RI. GnRH antagonist-induced gonadotropin withdrawal acutely, and specifically impairs spermatogonial development in the adult macaque (Macaca fascicularis). J Reprod Fertil. In press.
37. O'Donnell L, McLachlan RI, Wreford NG, de Kretser DM, Robertson DM. 1996 Testosterone withdrawal promotes stage-specific detachment of round spermatids from the rat seminiferous epithelium. Biol Reprod. 55:895-901.
38. McLachlan RI, Wreford NG, Tsonis C, de Kretser DM, Robertson DM. 1994 Testosterone effects on spermatogenesis in the GnRH-immunised rat. Biol Reprod. 50:271-280.
39. Cortes D, Muller J, Skakebaek NE. 1997 Proliferation of Sertoli cells during development of the human testis assessed by stereological methods. Int J Androl. 10:589-596.
40. Johnson L, Zane RS, Petty CS, Neaves WB. 1984 Quantification of the human Sertoli cell population: its distribution, relation to germ cell numbers, and age-related decline Biol Reprod. 31:785-795.
41. Tom L, Bhasin S, Salameh W, et al. 1992 Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate J Clin Endocrinol Metab. 75:476-483.
42. Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, Matsumoto AM. 1996 Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J Clin Endocrinol Metab. 81:757-762.
43. Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey M-A. 1996 Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab. 81:4113-4121.
44. Meriggiola MC, Bremner WJ, Paulsen CA, et al. 1996 A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. J Clin Endocrinol Metab. 81:3018-3023.
45. Kangasniemi M, Wilson G, Parchuri N, Huhtaniemi L, Meistrich ML. 1995 Rapid protection of rat spermatogenic stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen. Endocrinology. 136:2881-2888.
46. Tournaye H, Camus M, Goossens A, et al. 1995 Recent concepts in the management of infertility because of non-obstructive azoospermia. Hum Reprod. 10:115-119.